Differential expression of 5α-reductase isoenzymes in the human prostate and prostatic carcinomas

Prostate

Volumn 29, Issue 4, 1996, Pages 261-267

  Bonkhoff, Helmut ^a   Stein, Ute ^b   Aumüller, Gerhard ^b   Remberger, Klaus ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b NONE

Author keywords

5 reductase; prostate; prostate cancer

Indexed keywords

STEROID 5ALPHA REDUCTASE;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; ENZYME ACTIVITY; GENE EXPRESSION; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; TISSUE DISTRIBUTION; TUMOR CELL CULTURE;

ANDROGENS; CHOLESTENONE 5 ALPHA-REDUCTASE; CHROMOGRANIN A; CHROMOGRANINS; HUMANS; HYPERPLASIA; ISOENZYMES; MALE; OXIDOREDUCTASES; PROSTATE; PROSTATIC NEOPLASMS; REFERENCE VALUES; TISSUE DISTRIBUTION;

EID: 0029910571     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(199610)29:4<261::AID-PROS7>3.0.CO;2-E     Document Type: Article

References (33)

1. Davies P, Eaton CL: Regulation of prostate growth. Review. J Endocrinol 131:5-17, 1991.
2. Bruchovsky N, Wilson JD: The conversion of testosterone to andorstan-17β-ol-3-one by rat prostate in vivo and vitro. J Biol Chem 243:2012-2021, 1968.
3. Petrow V: The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications. Prostate 9:343, 1986.
4. Voigt KO, Bartsch W: Intratissular androgens in benigne hyperplasia and prostatic cancer. J Steroid Biochem 25:749-757, 1986.
5. Klein H, Bressel M, Kastendieck H, Voigt KD: Quantitive assessment of endogenous testicular and adrenal sex steroids and of steroid metabolizing enzymes in untreated human prostatic cancerous tissue. J Steroid Biochem 30:119-130, 1988.
6. Klein H, Bressel M, Kastendieck H, Voigt KD: Biochemical endocrinology of prostate cancer. In Voigt K-D, Knabbe C (eds): "Endocrine-Dependent Tumors." New York: Raven Press, 1991, 131-163.
7. Andersson S, Bishop RW, Russell DM: Expression of cloning of alpha-reductase, an enzyme essential for male sexual differentiation. J Biol Chem 264:16249-16255, 1991.
8. Andersson S, Bermann DM, Jenkins FP, Russell DW: Deletion 5 alpha 2 gene in male pseudohermaphroditism. Nature 354:159-161, 1991.
9. Normington K, Russell DW: Tissue distribution and kinetic characteristics of rat steroid 5 alpha-reductase. Evidence for distinct physiological functions. J Biol Chem 267:19548-19554, 1992.
10. Eicheler W, Tuohimaa P, Vilja P, Adermann K, Forssmann WE, Aumüller G: Immunohistochemical localization of human 5 alpha-reductase 2 with polyclonal antibodies in androgen target and non-target human tissues. J Histochem Cytochem 42:667-675, 1994.
11. Geller J: Nonsurgical treatment of prostatic hyperplasia. Cancer 70:339-345, 1992.
12. Böcking A, Krehn J, Heinzel-Wack M: Combined histological grading of prostatic cancer. Cancer 50:288-294, 1982.
13. Brawer MK: Prostatic intraepithelial neoplasia. A pre-malignant lesion. Hum Pathol 23:242-248, 1992.
14. Eicheler W, Bacher M, Seitz J, Adermann K, Forssmann WG, Aumüller G: Characterization and tissue distribution of 5 alpha-reductase using a polyclonal antibody. In Spera G, Fabrini A, Gnessi L, Bardin CW (eds): "Molecular and Cellular Biology of Reproduction." New York: Raven Press, 1992, p 257-265.
15. Eicheler W, Seitz J, Forssmann WG, Adernmann K, Aumüller G: Immunological characterization of rat liver 5 alpha-reductase. Eur J Cell Biol 60(suppl 3):151, 1993.
16. Bonkhoff H, Wernert N, Dhom G, Remberger K: Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic and neoplastic human prostate. Prostate 19:91-98, 1991.
17. Bonkhoff H, Stein U, Remberger K: Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic and neoplastic human prostate. Virchows Arch A Pathol Anat 423:291-294, 1993.
18. Aumüller G: Morphologic and endocrine aspects of prostatic function. Prostate 4:195, 1983.
19. English HF, Santen RJ, Isaacs JT: Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 11:229-242, 1987.
20. Isaacs JT, Coffey DS: Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl 2:33-50, 1989.
21. Bonkhoff H, Stein U, Remberger K: The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 24:114-118, 1994.
22. Bonkhoff H, Remberger K: Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate. Virchows Arch A Pathol Anat 422:35-38, 1993.
23. Bonkhoff H, Stein U, Remberger K: Multidirectional differentiation in the normal, hyperplastic and neoplastic human prostate. Simultaneous demonstration of cell specific epithelial markers. Hum Pathol 25:42-46, 1994.
24. Bonkhoff H, Remberger K: Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth. A stem cell model. Prostate 28:98-106, 1996.
25. Gittes RF: Carcinoma of the prostate. N Engl J Med 324:236-245, 1991.
26. Bruchovsky N, Brown EM, Coppin CM, Goldenberg SL, L E Riche JC, Murray NC, Rennie PS: The endocrinology and treatment of prostate tumor progression. Progr Clin Biol Res 239:347-387, 1987.
27. Isaacs JT: New principles in the management of metastatic cancer. Progr Clin Biol Res 185:383-405, 1985.
28. Quarmby VE, Beckmann WC Jr, Cooke DB, Lubahn DB, Joseph DR, Wilson EM, French FS: Expression and localization of androgen receptor in the R-3327 Dunning rat prostatic adenocarcinoma. Cancer Res 50:735-739, 1990.
29. Trapmann H, Ris-Stalpers C, Van der Korput JAGM, Kuiper GGJM, Faber PW, Romijn JC, Mulder E, Brinkmann AO: The androgen receptor functional structure and expression in transplanted human prostate tumor cell lines. J Steroid Biochem Mol Biol 37:837-842, 1990.
30. Van der Kwast TH, Schalken J, Ruizeveld de Winter JA, Van Vroonhoven CCJ, Mulder E, Boersma W, Trapman J: Androgen receptors in endocrine-therapy-resistant human prostate cancer. Int J Cancer 48:189-193, 1991.
31. Ruizeveld de Winter JA, Janssen PJA, Sleddens HMFB, Verleum-Mooijman MCT, Trapmann J, Brinkmann AO, Samerse AB, Schroeder FH, Van der Kwast TH: Androgen receptor status in localized and locally progressive, hormone refractory human prostate cancer. Am J Pathol 144:735-746, 1994.
32. Di Saint'Agnese PA: Neuroendocrine differentiation in carcinoma of the prostate. Cancer 70:254-268, 1992.
33. Di Saint'Agnese PA: Neuroendocrine differentiation in the prostate carcinoma. Hum Pathol 23:287-296, 1992.